Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Microbiotica, a UK-based developer of microbiome-based therapeutics and biomarkers spun out of Wellcome Sanger Institute, completed a £50m ($66.6m) series B round backed by commercialisation firm IP Group and patient capital fund Cambridge Innovation Capital (CIC) today. The round included internet group Tencent, as well as Flerie Invest, British Patient Capital and Seventure Partners. Seventure…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Talking Tech Transfer interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
